glp-1 receptor agonist drug names list of glp 1 medications GLP-1/GIP Agonists and Diabetic Retinopathy: What ODs Should Evolution of GLP‐1 Receptor Agonists

V., Gier, B., Elashoff, R

Therefore, the research and development of the relevant drugs and the replacement therapy of double GIP-GLP-1R agonists (e.g., tirzepatide) and triple GIP-GCG-GLP-1R (e.g., peptide 20) agonist are key research fields

This is associated with reduced capacity to utilize fatty acids and glucose, and this impairment promotes lipid accumulation within muscle, aggravating IR and muscle dysfunction

Understanding the mechanisms that drive the efficacy of this combination will no doubt be aggressively pursued in the coming years, along with the continued emergence of additional combinatorial approaches, further expanding pharmacological options for a more personalized metabolic medicine of the future

1 Introduction Glucagon-like peptide-1 (GLP-1) belongs to a class of intestinally derived hormones known as incretins ( Initial studies identified the pancreas as the primary site of GLP-1R expression